🇺🇸 FDA
Pipeline program

RHB-104

RHB-104-01

Phase 3 small_molecule completed

Quick answer

RHB-104 for Crohn's Disease is a Phase 3 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
RedHill Biopharma
Indication
Crohn's Disease
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials